- Advanced search
- Immuno Portal
- Malaria Portal
Ligand id: 7088
View more information in the IUPHAR Pharmacology Education Project: methylprednisolone
Molecular properties generated using the CDK
|Compound class||Metabolite or derivative|
|Approved drug?||Yes (FDA (1957))|
|WHO Essential Medicine||WHO Model List of Essential Medicines (21st List, 2019). Access PDF version.|
|International Nonproprietary Names|
|Medrol® | U-67590A|
|Methylprednisolone is a corticosteroid.
Marketed formulations may contain methylprednisolone acetate (PubChem CID 5877).
Methylprednisolone has been reported to activate the TRPC5 ion channel . Methylprednisolone-induced activation of TRPC5 is long lasting, reversible and sensitive to the TRPC5 inhibitor clemizole .
|CAS Registry No.||83-43-2|
|GtoPdb PubChem SID||178103666|
|Search Google for chemical match using the InChIKey||VHRSUDSXCMQTMA-PJHHCJLFSA-N|
|Search Google for chemicals with the same backbone||VHRSUDSXCMQTMA|
|Search PubMed clinical trials||methylprednisolone|
|Search PubMed titles||methylprednisolone|
|Search PubMed titles/abstracts||methylprednisolone|
|Search UniChem for chemical match using the InChIKey||VHRSUDSXCMQTMA-PJHHCJLFSA-N|
|Search UniChem for chemicals with the same backbone||VHRSUDSXCMQTMA|
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.✖
Cat. No. 4819